Contineum Therapeutics, Inc. (CTNM) income statement
CTNMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$8.68−0.36 (-3.98%)
Close on Nov 20, 2026Market cap $326.55MP/E –Yield –
Contineum Therapeutics, Inc. financial ratios
See a number that looks wrong?